Winter 2012 Newsletter
We're very proud of the progress YCCI has made in its first five years.
We've attracted and trained an impressive group of Scholars who have great potential for successful careers in clinical and translational research.
As YCCI moves into the next five years of its Clinical and Translational Science Award (CTSA), we have a good opportunity to highlight one of our foundational programs: Education and Training.
The newest round of Scholars is an accomplished group of investigators who are pursuing clinical and translational research projects aimed at some of the most challenging areas found in medicine today.
Mathieu Lemaire, MSc, MDCM, a trainee in Yale's innovative Investigative Medicine Program, is conducting translational research in genomics to explore the underlying causes of renal disease.
Mona Sadeghpour, MD '12, a TL1 trainee, is investigating the role of Langerhans cells in UV-induced skin cancers during her fifth year of medical school.
Scientific advances in neuroscience and genetics may be on the verge of producing fundamental transformations in psychiatry. Combined with a shortage of psychiatry trainees, these changes amount to a turning point for the field.
On March 9, YCCI will be hosting an event open to all trainees in the Schools of Medicine, Nursing and Public Health that offers the opportunity for all Yale Scholars to learn from their colleagues.
Yale is one of four sites in the country to provide research training through the Robert Wood Johnson (RWJ) Foundation Clinical Scholars Program, a two-year fellowship program that seeks to develop health leaders and influence the quality of health care.